CDSCO Approves Aurobindo CuraTeQ's Bevacizumab Biosimilar Bevqolva for Cancer Treatment Parthika Patel17 May 2026 10:22 PM ISTNew Delhi: Aurobindo Pharma on Friday announced that its wholly owned subsidiary CuraTeQ Biologics Pvt Ltd has received marketing authorisation from...
Aurobindo Arm CuraTeQ Secures Health Canada Nod for Cancer Biosimilar Bevqolva sheeba farhat4 May 2026 11:00 PM ISTNew Delhi: Aurobindo Pharma on Friday said its arm CuraTeQ Biologics has received a compliance notice from Health Canada's Biologics and...
Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer Ruchika Sharma17 Sept 2025 1:03 PM ISTRahway: Merck, Daiichi Sankyo have announced that Raludotatug deruxtecan (R-DXd) has received Breakthrough Therapy Designation (BTD) from the U.S....
CDSCO Panel Nod To Phase I Clinical Trial of Anticancer Drug Bevacizumab by Jeevan Scientific Susmita Roy14 Sept 2025 11:30 AM ISTNew Delhi: Noting that the drug product is approved in the country of origin, the Subject Expert Committee (SEC), functional under the Central Drugs...
Anti-VEGF Eye Injections tied to minor Increase in Stroke Risk, suggests research Dr. Shravani Dali5 Sept 2025 8:15 PM ISTA recent nationwide case-control study published in Acta Ophthalmologica found that intravitreal injections of anti-VEGF agents for neovascular...
Use of Bevacizumab in Lung Cancer Patient linked to rare kidney complication: Case Report Medha Baranwal15 Aug 2025 8:45 PM ISTChina: A team from The Second Clinical College of Guangzhou University of Chinese Medicine, led by Rui Jiang, has documented a rare case of...
Alkem Launches 'PRAYAS': A Bold Step Toward Accessible Cancer Care Deeksha Bhandari4 July 2025 12:00 PM ISTIn a significant patient-centric move, Alkem Laboratories Ltd., one of India's largest pharmaceutical companies, has launched PRAYAS- a...
Biocon, NCSM partner to launch oncology support program Ruchika Sharma24 Jun 2025 10:15 AM ISTThis collaboration combines Biocon's expertise in biosimilars with NCSM's community outreach to enhance cancer care accessibility, affordability in...
Bevacizumab and erlotinib combo effective in papillary renal-cell carcinoma patients: NEJM Jacinthlyn Sylvia23 Jun 2025 10:00 PM ISTA new study published in The New England Journal of Medicine showed that bevacizumab and erlotinib together demonstrated efficacy in individuals with...
HIV Drug Lamivudine Shows Early Vision Improvement in Diabetic Macular Edema: Study Dr Riya Dave8 Jun 2025 9:15 PM ISTA study published in Med has found that the HIV medication lamivudine significantly improved visual acuity in adults with diabetic macular edema by...
Intas Pharmaceuticals Gets CDSCO Panel Nod To study Bevacizumab Solution for Injection Dr. Divya Colin12 March 2025 5:45 PM ISTNew Delhi: Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Aurobindo Pharma arm CuraTeQ Biologics gets UK MHRA nod for cancer treatment Bevqolva Ruchika Sharma22 Dec 2024 1:30 PM ISTHyderabad: CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma Limited, has announced that it has obtained marketing...
